Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| RenovoRx Inc | RNXT | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 1.21 | 04:43:11 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.21 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 0.5306 - 3.29 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 1.21 | USD |
RenovoRx Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 12.94M | 10.69M | - | 0 | -10.23M | -0.96 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
RenovoRx News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RNXT Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.22 | 1.38 | 1.19 | 1.23 | 10,675 | -0.01 | -0.82% |
| 1 Month | 1.22 | 1.56 | 1.10 | 1.18 | 62,331 | -0.01 | -0.82% |
| 3 Months | 1.65 | 1.86 | 1.10 | 1.33 | 39,331 | -0.44 | -26.67% |
| 6 Months | 1.15 | 2.35 | 0.5306 | 1.41 | 67,979 | 0.06 | 5.22% |
| 1 Year | 3.05 | 3.29 | 0.5306 | 2.21 | 188,754 | -1.84 | -60.33% |
| 3 Years | 8.25 | 16.74 | 0.5306 | 7.73 | 465,252 | -7.04 | -85.33% |
| 5 Years | 8.25 | 16.74 | 0.5306 | 7.73 | 465,252 | -7.04 | -85.33% |
RenovoRx Description
| RenovoRx Inc is a clinical-stage biopharmaceutical company. It is focused on developing therapies for the local treatment of solid tumors and conducting a Phase 3 registrational trial for lead product candidate RenovoGem. |
